These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 37288831)

  • 1. A single-center experience of post-transplant atypical hemolytic uremic syndrome.
    Abu Jawdeh BG; Khan MA
    Clin Nephrol; 2023 Aug; 100(2):75-81. PubMed ID: 37288831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report.
    Dedhia P; Govil A; Mogilishetty G; Alloway RR; Woodle ES; Abu Jawdeh BG
    Transplant Proc; 2017; 49(1):188-192. PubMed ID: 28104134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M; Moran SM; Smith RJ; Ren KYM; Smith GN; Shamseddin MK; Avila-Casado C; Garland JS
    Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number variation analysis using next-generation sequencing identifies the
    Park J; Yhim HY; Kang KP; Bae TW; Cho YG
    Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion.
    Diep J; Potter D; Mai J; Hsu D
    BMC Nephrol; 2023 May; 24(1):127. PubMed ID: 37147581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Infant Case of Streptococcus Pneumoniae-Associated Thrombotic Microangiopathy with Heterozygous CFI Mutation and CFHR3-CFHR1 Deletion.
    Matsumoto Y; Ikezumi Y; Kondoh T; Yokoi K; Nakajima Y; Kumagai N; Kato T; Kurahashi H; Ito T
    Tohoku J Exp Med; 2022 Oct; 258(3):183-193. PubMed ID: 36070894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M
    Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
    Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo thrombotic microangiopathy in two kidney transplant recipients from the same deceased donor: A case series.
    Roberts D; Siegman I; Andeen N; Woodland D; Deloughery T; Rueda J; Olyaei A; Rehman S; Norman D; Lockridge J
    Clin Transplant; 2020 Jul; 34(7):e13885. PubMed ID: 32314417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome.
    Raina R; Mangat G; Hong G; Shah R; Nair N; Abboud B; Bagga S; Sethi SK
    Front Immunol; 2022; 13():931210. PubMed ID: 36091034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo systemic atypical hemolytic uremic syndrome in an ABO-incompatible living kidney transplant recipient with a novel pathogenic CFHR1 gene mutation successfully treated with eculizumab: a case report.
    Li D; Wang W; Chen R; Wen J; Zhang M
    J Nephrol; 2022 Sep; 35(7):1895-1899. PubMed ID: 35852773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-Threatening Diffuse Alveolar Hemorrhage and Graft Failure in Atypical Hemolytic Uremic Syndrome with C3 Gene Mutation following Kidney Transplant.
    Song JY; Oh SH; Kim Y
    Nephron; 2024; 148(7):474-479. PubMed ID: 38008090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K; Seeman T
    Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS.
    Favi E; Molinari P; Alfieri C; Castellano G; Ferraresso M; Cresseri D
    Front Immunol; 2022; 13():1073808. PubMed ID: 36591301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene.
    Román-Ortiz E; Mendizabal Oteiza S; Pinto S; López-Trascasa M; Sánchez-Corral P; Rodríguez de Cordoba S
    Pediatr Nephrol; 2014 Jan; 29(1):149-53. PubMed ID: 23982707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.